Related Experiment Videos
Clinical and biochemical characteristics of prolidase deficiency in siblings
Insights
This study identifies a deficiency in prolidase enzyme activity in two brothers with severe skin ulcers and developmental issues. Their condition involves the abnormal excretion of imidodipeptides, particularly glycylproline, in urine and blood.
Area of Science:
- Biochemistry
- Genetics
- Dermatology
Background:
- Genetic disorders can manifest with complex clinical symptoms affecting multiple organ systems.
- Enzyme deficiencies are a key area of study in metabolic and genetic diseases.
- Imidodipeptides play roles in biological processes, and their abnormal metabolism can indicate disease.
Observation:
- Two brothers presented with recurrent lower limb skin ulcers, developmental abnormalities, poliosis, and intellectual impairment.
- Analysis revealed significant excretion of imidodipeptides, notably glycylproline, in the patients' urine and blood.
- Red blood cells and skin fibroblasts showed markedly deficient prolidase enzyme activity.
Findings:
- The patients exhibit a severe deficiency in prolidase enzyme activity, consistent with inherited prolidase deficiency.
- Elevated urinary and blood glycylproline levels serve as a biomarker for this enzymatic defect.
- The clinical phenotype is linked to the impaired breakdown of imidodipeptides.
Implications:
- This research contributes to the understanding of inherited metabolic disorders and their clinical presentations.
- Identifying prolidase deficiency is crucial for potential therapeutic interventions and genetic counseling.
- Further research into the pathophysiology of prolidase deficiency may reveal new treatment strategies.
Abstract:
Two brothers with recurrent skin ulcers of the lower limbs, subnormal intelligence, developmental abnormalities, and poliosis were found to excrete large quantities of several imidodipeptides in their urine. Glycylproline was the most prominent imidodipeptide excreted and was also detected in their blood. Prolidase activity was markedly deficient in red blood cells from both patients (4.1% and 3.7% of control mean) and skin fibroblasts from the one brother so examined (3.7% of control mean). A total of 20 patients with prolidase deficiency, including the two in this report, have been described in the literature. Their manifestations and various attempts at treatment are reviewed.